Dis-Chem Pharmacies Limited provided earnings guidance for the year ended 28 February 2017. For the period, the company expects to announce earnings per share (EPS) of between 72.8 cents and 76.0 cents being a decrease of between 64% and 66% compared to EPS of 212 cents for the corresponding period and headline earnings per share (HEPS) of between 72.6 cents and 75.7 cents, being a decrease of between 63% and 65% compared to the corresponding period being 206 cents. Earnings (attributable to shareholders) is expected to be in the range of ZAR 605.075 million to ZAR 615.33 million and headline earnings is expected to be in the range of ZAR 597.878 million to ZAR 612.825 million.